IMMUTEP LIMITED — Director's Dealing 2025

Dec 4, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	IMMUTEP LIMITED (ASX: IMM)
ABN	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Lis (Elisabeth) Boyce
Date of last notice	10 December 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Lis (Elisabeth) Boyce
Date of change	2 December 2025
No. of securities held prior to change	1.) 256,621 Fully Paid Ordinary Shares2.) 333,334 Director Performance Rights
Class	1. Performance Rights (ASX: IMMAM)2. Fully Paid Ordinary Shares (ASX:IMM)
Number acquired	1.) 707,232 Performance Rights(ASX:IMAM)2.) 166,667 Fully Paid Ordinary Shares(ASX: IMM)
Number disposed	166,667 Performance Rights (ASX: IMMAM)

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	N/AThe Performance Rights were issued asremuneration for services as a director inaccordance with the shareholder approvalobtained at the Annual General Meeting held on27 November 2025. Lis Boyce is taking 55% ofher fees for the period 1 December 2025 to 30November 2028 in Performance Rights whichwill vest in accordance with the terms set out inthe Notice of Annual General Meeting.
No. of securities held after change	1.) 423,288 Fully Paid Ordinary Shares2.) 166,667 Performance Rights approvedat 2023 AGM3.) 707,232PerformanceRightsapproved at 2025AGM
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	707,232 Performance Rights were acquired inaccordancewithshareholderapprovalobtained at the Annual General Meeting on 27November 2025.166,667 shares were issued upon vesting andexercising of 3rd tranche of PerformanceRights out of the 589,955 Performance Rightswhich were issued in lieu of cash to Ms Boycein accordance with the Shareholders approvalobtained at the 2023 AGM.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	N.A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above	No
traded during a+closed period where prior written clearance
was required?
If so, was prior written clearance provided to allow the trade to	N/A
proceed during this period?
If prior written clearance was provided, on what date was this	N/A
provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3